Loading…
Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I
A recombinant soluble bovine tumor necrosis factor receptor type I (sboTNF-RI) was expressed in the methylotrophic yeast Pichia pastoris and evaluated for its ability to inhibit bovine tumor necrosis factor alpha (TNF-α) cytotoxicity. A cDNA encoding the extracellular domain of bovine TNF-RI was pla...
Saved in:
Published in: | Veterinary immunology and immunopathology 2000-12, Vol.77 (3), p.233-241 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A recombinant soluble bovine tumor necrosis factor receptor type I (sboTNF-RI) was expressed in the methylotrophic yeast
Pichia pastoris and evaluated for its ability to inhibit bovine tumor necrosis factor alpha (TNF-α) cytotoxicity. A cDNA encoding the extracellular domain of bovine TNF-RI was placed under the control of the powerful and tightly regulated alcohol oxidase1 (AOX1) gene promoter of the pPICZa A vector and the resulting construct integrated into the 5′ region of the alcohol oxidase genes of GS115 and KM71 strains of
Pichia. Soluble bovine TNF-RI was secreted into the medium following induction of the AOX1 gene promoter with methanol, and purified to greater than 95% purity by ion-exchange chromatography. In in vitro assays, the purified recombinant sboTNF-RI will block the cytolytic activity of bovine TNF-α on WEHI 164 cells clone 13 by 50% when used at a concentration of 170
μg/ml, and by nearly 90% when used at a concentration of 310
μg/ml. Results of this study suggest that recombinant sboTNF-RI may have therapeutic value as a TNF inhibitor in cattle with coliform mastitis. |
---|---|
ISSN: | 0165-2427 1873-2534 |
DOI: | 10.1016/S0165-2427(00)00244-0 |